Organization Overview
Historical Acquisition Tree
Alternative names
belumosudil (Rezurock) (2021 NDA)
interferon alfacon-1 (Infergen) (1997 NDA)
ribavirin (virazole) (2004)
Autoimmune Diseases (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Colorectal Neoplasms (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Fibrosis (Phase 2)
Glioblastoma (Phase 2)
Graft vs Host Disease (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 3)
Hyperlipidemias (Phase 2)
Hyperlipoproteinemias (Phase 2)
Hypertension (Phase 2)
Hypertriglyceridemia (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Kidney Diseases (Phase 2)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Meningeal Carcinomatosis (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 2)
Polycystic Kidney, Autosomal Dominant (Phase 2)
Polycystic Kidney, Autosomal Recessive (Phase 1)
Polycystic Kidney Diseases (Phase 2)
Psoriasis (Phase 2)
Pulmonary Fibrosis (Phase 2)
Raynaud Disease (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 2)